Latest Guidance News

Netwealth will acquire AI advice platform Paradino for up to $29 million and invest a further $10 million to scale the business. The deal extends Netwealth beyond platform administration into advice production, while Paradino remains loss-making and separately reported.

Meridian Energy’s generation rose 21.1% year on year in August as strong hydro and wind conditions pushed national storage to 155% of historical average. But average generation prices fell 62.3%, highlighting the tension between abundant supply and weaker market pricing.

Range International has replaced CEO Russell Kennett with Executive Chairman Richard Jenkins on an interim basis, with Jenkins to spend more time overseeing the company’s Indonesian operations. The restructure is expected to cut costs by up to 50%, although the company has not disclosed a baseline or implementation timetable.

Synertec has identified ANSTO as the client behind its $45.5 million engineering contract, with about $36 million of revenue expected during the first 26 months. The project could improve FY27 revenue, but the company has not yet revised its guidance.

Proteomics International has begun a controlled release of two Promarker diagnostic tests through Healius in Western Australia and the Northern Territory. National commercial sales are targeted for Q2 FY27, but uptake and revenue remain difficult to estimate at this early stage.

Manuka Resources has completed the issue of 207.1 million ordinary shares at AUD 0.07 each, adding an implied AUD 14.5 million in gross cash proceeds. The placement lifts quoted shares on issue to nearly 1.8 billion, making dilution the filing's clearest investor consequence.

Locality Planning Energy CEO Scott Taylor has stepped down, with a three-person interim leadership team taking charge while the board searches for a permanent successor. The company says its growth strategy remains unchanged, but has not set a timetable for the appointment.

Entropy Neurodynamics reported that all six patients in Cohort 1 of its Phase 2 BED trial maintained clinically meaningful improvement 12 weeks after two TRP-8803 infusions. Three patients experienced no binge-eating episodes during the 84-day follow-up, although the results come from a small, open-label study without a control group.

Stonehorse Energy has added 262 BOEPD from two new Alberta wells, lifting production from its Drumheller area above 500 BOEPD. Two further wells are online but still cleaning up, while the company plans more drilling before year-end.

Catalyst Metals has increased the Trident underground Ore Reserve by 32% to 524,000 ounces, supporting a planned mine life of more than 10 years. The result strengthens the company’s ambition to build a 2Moz Reserve base across the Plutonic Belt, although further growth depends on drilling and mine execution.

Boab Metals has reported high-grade silver-lead intercepts outside the current Sorby Hills FEED Study pit designs, led by 12.62 metres at 204g/t silver equivalent. The results have pushed the company to extend its growth drilling program as it assesses potential resource, reserve and mine-life additions.

Telix’s Pixclara has become the first FDA-approved FET-PET imaging drug for glioma, opening a new US diagnostic pathway for adults and children. The approval is commercially significant, but pricing, reimbursement and launch timing remain undisclosed.